CN108892724A - A kind of preparation method of Vip3Aa20 rabbit polyclonal antibody - Google Patents

A kind of preparation method of Vip3Aa20 rabbit polyclonal antibody Download PDF

Info

Publication number
CN108892724A
CN108892724A CN201810746540.2A CN201810746540A CN108892724A CN 108892724 A CN108892724 A CN 108892724A CN 201810746540 A CN201810746540 A CN 201810746540A CN 108892724 A CN108892724 A CN 108892724A
Authority
CN
China
Prior art keywords
vip3aa20
polyclonal antibody
protein
preparation
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201810746540.2A
Other languages
Chinese (zh)
Inventor
刘卫晓
金芜军
李亮
宛煜嵩
黄卫红
苗朝华
高进
董美
王迪
张哲�
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biotechnology Research Institute of CAAS
Original Assignee
Biotechnology Research Institute of CAAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotechnology Research Institute of CAAS filed Critical Biotechnology Research Institute of CAAS
Priority to CN201810746540.2A priority Critical patent/CN108892724A/en
Publication of CN108892724A publication Critical patent/CN108892724A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
    • C07K16/1278Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Bacillus (G)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/32Assays involving biological materials from specific organisms or of a specific nature from bacteria from Bacillus (G)
    • G01N2333/325Bacillus thuringiensis crystal protein (delta-endotoxin)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)

Abstract

The invention discloses a kind of preparation method for the Vip3Aa20 rabbit polyclonal antibody for belonging to technical field of bioengineering, the preparation method of the polyclonal antibody includes the following steps:A) Vip3Aa20 recombinant protein is obtained by prokaryotic expression;B) animal is immunized:Japan large ear rabbit is immunized using Vip3Aa20 recombinant protein as antigen;C) bioactivity;D) polyclonal antibody purification and western verifying.The polyclonal antibody is to realize that qualitative and quantitative analysis of the insect resistance protein Vip3Aa20 in transgenic corns MIR162 lays the foundation.

Description

A kind of preparation method of Vip3Aa20 rabbit polyclonal antibody
Technical field
The present invention relates to bioengineering fields, and in particular to a kind of preparation method of Vip3Aa20 rabbit polyclonal antibody.
Background technique
Dipel (Bacillus thuringiensis, Bt) is a kind of gram sun being widely present in soil Property bacterium, there is high pest-resistant active soluble protein (Vegetative Insecticidal in vegetative growth phase secretion Proteins,Vip proteins).The table of Vip3 albumen can be detected to spore phase, supernatant of bacteria solution is produced in 15 hours of inoculation It reaches.Insect resistance protein Vip3 has extensive toxicity to lepidoptera (Lepidoptera) insect, after insect's food-taking Vip3 albumen, the egg White through Midgut protein enzyme activation, the albumen of activation penetrates funnel, in conjunction with the epithelial cell teleblem differential protein of midgut epithelial cells And enterobrosis is formed, to destroy the osmotic equilibrium of cell, cellular swelling is caused to crack, eventually leads to death.Therefore Vip3 base Because having become most potential and application prospect anti insect gene in plant genetic engineering and transgenic breeding application.Wherein Vip3Aa gene is successfully used for transgene cotton and corn.
While bringing tremendous economic interests, people also make by increasingly concern transgenosis for the rapid development of genetically modified crops The possible not expected edible safety of object and environmental safety problem, more and more national requirements are to transgenic product It is detected to carry out mark system.
The information disclosed in the background technology section is intended only to increase the understanding to general background of the invention, without answering When being considered as recognizing or imply that the information constitutes the prior art already known to those of ordinary skill in the art in any form.
Summary of the invention
The purpose of the present invention is to provide a kind of preparation method of Vip3Aa20 rabbit polyclonal antibody, obtain its more and resist be Realize that qualitative and quantitative analysis of the insect resistance protein Vip3Aa20 in transgenic corns MIR162 lays the foundation.
To achieve the above object, the present invention provides a kind of preparation method of Vip3Aa20 polyclonal antibody, including it is following Step:
A) Vip3Aa20 recombinant protein is obtained by prokaryotic expression;
B) animal is immunized:Japan large ear rabbit is immunized using Vip3Aa20 recombinant protein as antigen;
C) bioactivity:Using indirect elisa method, gradient dilution is carried out to antibody and detects the potency of antibody and sensitive Degree;
D) polyclonal antibody purification:Using Protein G affinity chromatography, polyclonal antibody is obtained.
Above-mentioned polyclonal antibody detects obtained potency by indirect ELISA and is followed successively by 1:512000.
The present invention also provides application of the above-mentioned polyclonal antibody in detection Vip3Aa20 insect resistance protein.
The present invention also provides above-mentioned polyclonal antibodies in the reagent of preparation ELISA method detection Vip3Aa20 insect resistance protein Application.
The present invention also provides above-mentioned polyclonal antibodies to detect the pest-resistant egg of Vip3Aa20 in preparation ELISA double antibody sandwich method Application in white reagent.
Beneficial effects of the present invention:The high-purity insect resistance protein that utilizing works bacterial strain of the present invention is expressed, purifying obtains Vip3Aa20 obtains the antibody indirect ELISA potency that antiserum obtains after purification as antigen, by the way that Japan large ear rabbit is immunized It is 1:512000, the polyclonal antibody can be with the recombination Vip3Aa20 albumen and transgenic corns of specific recognition prokaryotic expression Endogenous Vip3Aa20 albumen in MIR162 standard items, the rabbit polyclonal antibody of Vip3Aa20 insect resistance protein are configured to transgenosis The detection of the albumen provides substance and technical support in crop.
Detailed description of the invention
Fig. 1 is Vip3Aa20 recombinant protein SDS-PAGE electrophoresis result figure.
Fig. 2 is Vip3Aa20 recombinant protein polyclonal antibody western result figure, secondary antibody:IgG(H+L)-HRP(1: 5000)。
Fig. 3 is the SDS-PAGE electrophoresis result figure after polyclonal antibody purification.
Fig. 4 is polyclonal antibody titre.
Fig. 5 is in polyclonal antibody specific detection Vip3Aa20 recombinant protein and transgenic corns MIR162 Vip3Aa20 Western result figure.
Specific embodiment
With reference to the accompanying drawing, specific embodiments of the present invention will be described in detail, it is to be understood that guarantor of the invention Shield range is not limited by the specific implementation.
Experimental method used in following embodiments is conventional method unless otherwise specified.
The materials, reagents and the like used in the following examples, it is unless otherwise specified, commercially commercially available.
Embodiment 1
1. the preparation of immunizing antigen
(1) recombinant protein Vip3Aa20 expresses strain construction, thallus culture and cracking
The amplification of Vip3Aa20 encoding gene:Using transgenic corns MIR162 genomic DNA as template, vip3a20-NdeI- F:Catatggctagcatgactggtggacagc and vip3a20-XhoI-R:Ctcgagctacttgatgctcacgtc is to draw Object carries out PCR amplification with high-fidelity Fastpfu, and the PCR product expanded, will after the identification of (1.0%) agarose gel electrophoresis Purpose band gel extraction is recycled with Universal DNA purification and recovery kit (Tiangeng), and recovery product is through restriction enzyme Enzyme Bam HI and XhoI digestion are recycled through glue and are stayed overnight with the pET28a plasmid fragments for carrying out same digestion, glue recovery processing in 4 DEG C Connection, conversion Trans10 competent cell (the full formula gold in Beijing), picked clones carry out bacterium colony PCR identification, and positive colony is by north Capital six directions Huada gene company is sequenced.
It will identify that correct recombinant expression carrier pET28a-vip3Aa20 conversion e. coli bl21 (DE3) competence is thin Born of the same parents, bacterium solution are coated on the LB plate containing kanamycins (50 μ g/mL), and 37 DEG C are incubated overnight.Next day picking Dan Ke on plate In the LB liquid medium of grand inoculation kanamycins containing same concentrations, it is incubated overnight in 37 DEG C.Resulting expression bacterial strain bacterium solution with 50% glycerite mixes in equal volume, in -80 DEG C of cold storage.
By the recombinant protein Vip3Aa20 expression bacterial strain recovery culture of preservation, bacterium solution is coated on containing kanamycins (50 μ g/ ML on LB plate), 37 DEG C are incubated overnight.Picking monoclonal is inoculated with 37 in liquid LB (the 50 μ g/mL containing kanamycins) culture medium It DEG C is incubated overnight.It with the inoculation of 1% inoculum concentration, cultivates in 37 DEG C to OD within second day600It is 0.8 or so, 1mM IPTG is added in 16 DEG C Induction expression protein overnight.Induction terminates bacterium solution ice bath, and in 4 DEG C, thalline were collected by centrifugation by 4000rpm, 10min, abandons supernatant, bacterium Body is suspended after PBS is washed with lysate (50mM Tris pH7.5,300mM NaCl, 5%Glycerol and 20mM imidazoles); Ultrasonication (2s on/4s off, Amp:45%, Time:3min);4 DEG C of 15000rpm are centrifuged 1hr, collect supernatant.
(2) recombinant protein purification
Cellular lysate liquid supernatant and the Ni Sepharose 6FF Beads (GE Healthcare) through lysate balance are mixed It closes, 2-3hrs, 3000rpm is combined to be centrifuged 3min and abandon supernatant in 4 DEG C;Protein-bonded Ni Sepharose 6FF beads warp Cleaning solution (50mM Tris pH7.5,300mM NaCL, 5%Glycerol and 50mM imidazoles) is washed 2-3 times;Eluent is used again (50mM Tris pH7.5,300mM NaCL, 5%Glycerol and 200mM imidazoles) elution.Collecting eluent is that albumen is thick Pure solution.
The protein sample that affinity purification is obtained is dialysed to protein storage solution (50mM Tris pH7.5,300mM NaCL, 5%Glycerol), and with the 200 Increase 10/30GL (GE of Superdex balanced through same solution Healthcare it) is further purified, collects protein peak component and the purity through SDS-PAGE detection protein sample, it can by Fig. 1 , electrophoretically pure Vip3Aa20 albumen is finally obtained by gel filtration, molecular weight is about 90KD.
2. immune animal
Use the Vip3Aa20 recombinant protein of above-mentioned Quality Control qualification that the big ear of SPF grade Japan at 3 3-5 monthly ages is immunized as antigen White rabbit (is purchased in Hubei Province Animal Experimental Study center, credit number:SCXK (Hubei Province) 2015-0018), antigen with it is isometric complete Full Freund's adjuvant (head exempts from) and incomplete Freund's adjuvant (booster immunization) are mixed and are emulsified, and are fully mixed to Water-In-Oil state It is immune to carry out subcutaneous multiple spot, 2-3 booster immunization in 2 weeks each immunization interval periods, carries out bioactivity later, be higher than>1: Abdominal cavity impact is carried out after 10000 in 1 week, is directly dissolved in the antigen of immunizing dose in the PBS of 250 μ L, specific immune time and Immunizing dose is as shown in table 1:
1 immune time of table and immunizing dose
Vip3Aa20 recombinant protein polyclonal antibody western result figure, secondary antibody:IgG(H+L)-HRP(1:5000) as schemed Shown in 2.
3 polyclonal antibody purifications
Antiserum after collection selects Protein G- agarose affinity chromatography column purification, specific steps after pretreatment It is as follows:
1) balance chromatographic column is washed with the PBS of 10 times of column volumes (or TBS, similarly hereinafter).
2) after the serum containing antibody or other body fluid high speed centrifugations, supernatant is mixed with isometric 2 × PBS buffer solution, is adjusted After whole pH and ion concentration, it is slowly added to chromatographic column.
3) it is washed with PBS more than 10 times of column volumes, until efflux is detected without albumen.
4) 2 times of column volume 0.1M citric acids (Citrate Acid, pH 2.7) are added, clamp effuser, stand after five minutes Collection is pierced by liquid, in triplicate.It measures OD280 and estimates antibody concentration, if gained antibody is more to can be used SDS-PAGE inspection Survey purity.Also it can choose 0.1M glycine (Glycine, pH 3.0) elution.
5) the 1M Tris, pH 8.0 that 2/5 volume is added in the antibody after eluting is neutralized, and uses Millipore protein concentration pipe It is switched to required buffer liquid, usually 2 × PBS contains 0.02%NaN3 and 1mMEDTA.
6) it is concentrated to required volume, detects purity (see Fig. 3) by SDS-PAGE, -20 DEG C of preservations avoid freezing.
4. the titration of polyclonal antibody
By purified polyclonal antibody, using recombinant protein Vip3Aa20 as antigen, its effect is detected with indirect ELISA method Valence is measured through ELISA as shown in Figure 4, and the anti-titre of the polyclonal antibody purified is 1:512000.
5. polyclonal antibody specific detection
Transgenic corns MIR162 standard items are extracted respectively and its to convert the albumen of parental seed powder, run SDS-PAGE Glue, transferring film use purified polyclonal antibodies as primary antibody, 680 goat anti-rabbit IgG (H+L) of Alexa FlurorTM (Invitrogen) be secondary antibody, with Odyssey infrared740 imager (9120, Li-COR Biosciences, Lincolin, NE) infrared scanner western testing result, as shown in Figure 5, the Anti-TNF-α physical efficiency purified is special Identify the Vip3Aa20 and recombinant protein Vip3Aa20 in endogenous sample MIR162;
Wherein, transgenic corns MIR162 standard items (AOCS 1208-A, USA) protein extracting method:
Liquid nitrogen flash freezer is organized, is ground, 1mL (by sample size, general 0.5g adds 1-2mL) protein extract is added, 4 DEG C mix 30 Minute, (12,000rpm 4 DEG C of centrifugation 15min, take supernatant), protein extraction formula of liquid is shown in Table 2:
2 protein extraction formula of liquid of table
The aforementioned description to specific exemplary embodiment of the invention is in order to illustrate and illustration purpose.These descriptions It is not wishing to limit the invention to disclosed precise forms, and it will be apparent that according to the above instruction, can much be changed And variation.The purpose of selecting and describing the exemplary embodiment is that explaining specific principle of the invention and its actually answering With so that those skilled in the art can be realized and utilize a variety of different exemplary implementation schemes of the invention and Various chooses and changes.The scope of the present invention is intended to be limited by claims and its equivalents.

Claims (6)

1. a kind of preparation method of Vip3Aa20 rabbit polyclonal antibody, which is characterized in that include the following steps:
A) Vip3Aa20 recombinant protein is obtained by prokaryotic expression;
B) animal is immunized:White rabbit is immunized using Vip3Aa20 recombinant protein as antigen;
C) bioactivity:Using indirect elisa method, gradient dilution is carried out to antibody and detects the potency and sensitivity of antibody;
D) polyclonal antibody purification:Using Protein G affinity chromatography, polyclonal antibody is obtained.
2. preparation method according to claim 1, which is characterized in that the immune white rabbit of the Vip3Aa20 recombinant protein For Japan large ear rabbit.
3. polyclonal antibody according to claim 2, it is characterised in that generated polyclonal antibody passes through indirect ELISA It detects obtained potency and is followed successively by 1:512000.
4. application of the polyclonal antibody described in claim 1 in detection Vip3Aa20 insect resistance protein.
5. polyclonal antibody described in claim 1 answering in the reagent of preparation ELISA method detection Vip3Aa20 insect resistance protein With.
6. polyclonal antibody described in claim 1 is detecting Vip3Aa20 insect resistance protein in preparation ELISA double antibody sandwich method Reagent in application.
CN201810746540.2A 2018-07-09 2018-07-09 A kind of preparation method of Vip3Aa20 rabbit polyclonal antibody Pending CN108892724A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201810746540.2A CN108892724A (en) 2018-07-09 2018-07-09 A kind of preparation method of Vip3Aa20 rabbit polyclonal antibody

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201810746540.2A CN108892724A (en) 2018-07-09 2018-07-09 A kind of preparation method of Vip3Aa20 rabbit polyclonal antibody

Publications (1)

Publication Number Publication Date
CN108892724A true CN108892724A (en) 2018-11-27

Family

ID=64348694

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201810746540.2A Pending CN108892724A (en) 2018-07-09 2018-07-09 A kind of preparation method of Vip3Aa20 rabbit polyclonal antibody

Country Status (1)

Country Link
CN (1) CN108892724A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113493512A (en) * 2021-07-26 2021-10-12 中国农业科学院生物技术研究所 Preparation method of Cry3Bb rabbit polyclonal antibody

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101548011A (en) * 2006-06-03 2009-09-30 先正达参股股份有限公司 Corn event MIR162
WO2011075588A1 (en) * 2009-12-16 2011-06-23 Dow Agrosciences Llc COMBINED USE OF CRY1Ca AND CRY1Fa PROTEINS FOR INSECT RESISTANCE MANAGEMENT
CN108004215A (en) * 2017-12-13 2018-05-08 中国农业科学院生物技术研究所 Hybridoma cell strain and its antibody and preparation method of generation

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101548011A (en) * 2006-06-03 2009-09-30 先正达参股股份有限公司 Corn event MIR162
WO2011075588A1 (en) * 2009-12-16 2011-06-23 Dow Agrosciences Llc COMBINED USE OF CRY1Ca AND CRY1Fa PROTEINS FOR INSECT RESISTANCE MANAGEMENT
CN102821596A (en) * 2009-12-16 2012-12-12 陶氏益农公司 Combined use of CRY1Ca and CRY1Fa proteins for insect resistance management
CN108004215A (en) * 2017-12-13 2018-05-08 中国农业科学院生物技术研究所 Hybridoma cell strain and its antibody and preparation method of generation

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
R C ARGÔLO-FILHO等: "Immunodetection of the toxic portion of Vip3A reveals differential temporal regulation of its secretion among Bacillus thuringiensis strains", 《JOURNAL OF APPLIED MICROBIOLOGY》 *
陈建武等: "苏云金杆菌vip3 A基因的克隆、表达及杀虫活性分析", 《生物工程学报》 *
韩丽珍等: "苏云金芽孢杆菌营养期杀虫蛋白VIP3研究进展", 《基因组学与应用生物学》 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113493512A (en) * 2021-07-26 2021-10-12 中国农业科学院生物技术研究所 Preparation method of Cry3Bb rabbit polyclonal antibody

Similar Documents

Publication Publication Date Title
CN113699118B (en) Hybridoma cell strain, antibody produced by hybridoma cell strain and application of hybridoma cell strain
CN108004215B (en) Hybridoma cell strain, antibody produced by hybridoma cell strain and preparation method of antibody
CN114292820B (en) Insect-resistant protein Cry3Bb hybridoma cell strain, antibody produced by same and application thereof
CN104844712A (en) Streptococcus pneumonia protein antigen, and preparation method and application thereof
CN109777785B (en) Hybridoma cell strain and application thereof
CN109971726B (en) Hybridoma cell strain, antibody produced by hybridoma cell strain and preparation method of antibody
CN108892724A (en) A kind of preparation method of Vip3Aa20 rabbit polyclonal antibody
CN110724192B (en) Hybridoma cell strain secreting serpentine monoclonal antibody and application thereof
CN105543177B (en) Secrete hybridoma cell strain and its monoclonal antibody application of anti-citrus yellow vein clearing virus monoclonal antibody
CN111978410A (en) Fusion protein of brucella outer membrane protein OMP25 and periplasmic protein BP26 as well as expression and application thereof
CN114426955B (en) Insect-resistant protein Cry3Bb hybridoma cell strain, antibody produced by same and application thereof
CN113493511A (en) Preparation method of Cry1Fa rabbit polyclonal antibody
CN114280306B (en) ELISA detection kit and detection method for eleusine indica EPSPS protein
CN109541199A (en) A kind of immune colloid gold test paper and preparation method thereof of quick detection Mycoplasma bovis
CN110894234B (en) Monoclonal antibody capable of recognizing alternaria and hybridoma cell strain AaC5 thereof
CN103288954A (en) Monoclonal antibody with rock bream iridovirus ORF049L recombinant proteins and preparation method thereof
CN112342198A (en) PAT/PAT monoclonal antibody hybridoma cell strain, antibody produced by same and preparation method thereof
CN110205300B (en) Bar monoclonal antibody hybridoma cell strain, antibody produced by same and preparation method thereof
CN117143831B (en) Insect-resistant protein hybridoma cell strain, antibody produced by same and application thereof
CN110804094A (en) Monoclonal antibody for identifying alternaria tenuis and hybridoma cell strain AtD2 thereof
CN117143832B (en) Insect-resistant protein Cry1Ah hybridoma cell strain, antibody produced by same and application thereof
CN110862452B (en) Monoclonal antibody capable of recognizing alternaria and hybridoma cell strain AaA1 thereof
CN110804092B (en) Monoclonal antibody for recognizing alternaria tenuis and hybridoma cell strain AtA8 thereof
CN110894232B (en) Monoclonal antibody for recognizing alternaria tenuis and hybridoma cell strain AtA1 thereof
CN113493512A (en) Preparation method of Cry3Bb rabbit polyclonal antibody

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20181127

RJ01 Rejection of invention patent application after publication